In a powerful show of appreciation for the individuals who run toward danger when the world calls, BTL Industries is proud to announce the launch of its latest BTL Cares initiative — a nationwide campaign to support the mental and physical health of firefighters.

Through partnerships with select clinics in high-risk wildfire regions, BTL will offer complimentary Exomind™ and Emsculpt Neo^® treatments to firefighters. These cutting-edge technologies address two of the most critical wellness challenges facing first responders today: mental fatigue and soft-tissue injury recovery.

"We believe that even the strongest deserve support," said John Ferris, VP of Marketing. "This is about showing up for those who show up for us every single day."

A Human Crisis Behind the Heroism

According to national data, up to 30% of firefighters experience behavioral health issues, including depression, PTSD, and anxiety — often worsened by physical injury, lack of recovery time, and repeated trauma exposure. Yet, many remain reluctant to seek help.

BTL's Firefighter Initiative aims to change that by offering a science-rooted, stigma-free path to healing. With non-invasive, FDA-cleared technology, firefighters can receive treatments that support mental clarity, physical recovery, and emotional resilience — all without medication, surgery, or downtime.

Why Exomind™ and Emsculpt Neo^®?

• Exomind™ supports brain function and emotional regulation using ExoTMS technology, stimulating key brain areas, restoring healthy brain activity and enhancing neural connectivity. This may help improve mood, mental clarity and emotional resilience.
• Emsculpt Neo^® delivers high-intensity focused electromagnetic energy to strengthen muscles and accelerate post-surgical or post-injury rehabilitation while increasing range of motion, mobility and flexibility.

Together, they form a comprehensive wellness protocol for first responders who give their all — often at great personal cost.

A National Call to Action

BTL invites medical providers, community leaders, and the media to join in amplifying the message: "Heroes Deserve Healing." Participating clinics will be recognized as Official BTL Cares Partners, complete with campaign materials and community engagement tools.

For more information on how to support or participate in the BTL Cares Firefighter Initiative, visit BodybyBTL.com

About BTL:
Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 200+ patents and over 500 in-house engineers, BTL leverages technology and science to advance medical treatments. Its product portfolio includes , EMSCULPT NEO^®, EMFACE^®, EXION™, EXOMIND™, EMSELLA^®, and others.

Media Contact:
Samantha Slaven-Bick
samantha@samanthaslaven.com 

BTL Industries, a global leader in medical and wellness technologies, has expanded the FDA-cleared applications of its EMFACE® platform with a new indication for the treatment of temporomandibular joint (TMJ) dysfunction.

EMFACE® is now cleared by the FDA for the relief of symptoms associated with muscle spasm, treatment of TMJ dysfunction and associated pain, muscle re-education, increased local blood flow, and the maintenance or improvement of mandibular range of motion.

Developed through years of research and engineering, EMFACE combines synchronized radiofrequency and HIFES® technology for facial muscle stimulation, delivering relief without surgery, injections, or medication.

"EMFACE is an established technology platform with multiple FDA-cleared uses," said David Chmel, CEO of BTL Industries. "This new indication allows dental, oral health, and wellness providers to address TMJ dysfunction within its approved uses, expanding the benefits of EMFACE to more patients."

"TMJ dysfunction impacts more than the jaw — it affects quality of life," said Shireen Dhanani, DMD, Leesburg, FL. "With EMFACE, we can now offer an accessible, non-invasive option that not only helps patients find relief and functional improvement, but also expands the scope of dental care."

BTL continues to redefine what's possible in facial care and wellness, bringing science-backed technologies like EMFACE into new areas of medicine to improve lives and advance patient care worldwide.

For more information about EMFACE, visit www.emface.com.

About BTL Industries

Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. Operating in over 90 countries, BTL holds more than 200 patents and employs over 500 R&D engineers dedicated to advancing medical treatments through technology and science. Its product portfolio includes EMSCULPT NEO®, EMFACE®, EXION™, EXOMIND™, EMSELLA®, and others.

Media Contact: samantha@samanthaslaven.com

BTL, the global leader in aesthetic and wellness technology, proudly announces the 6th annual National Emsculpt Week, taking place May 18–24, 2025. This year's celebration is bigger than ever. It combines provider recognition, real patient transformation, and community connection for an unforgettable week.

National Emsculpt Week spotlights the providers and patients who are embracing stronger bodies, functional wellness, and vibrant aging through Emsculpt^® and Emsculpt NEO^®. In 2025, BTL is taking things up a notch with a brand-new twist: a nationwide sweepstakes that will award free Emsculpt treatments to patients across the country. It's an exciting opportunity for people to jumpstart their wellness journeys and experience Emsculpt's muscle-building, confidence-boosting power firsthand.

The heart of the celebration is a national digital competition, offering exciting prizes for the most engaging provider posts across North America. Practices will post photos, reels, or stories showing their teams, patients, or favorite Emsculpt success moments. The most engaging and inspiring entries will win major prizes — including Emsculpt device applicators and the coveted Exion™ system with choice of applicator.

"This is more than just a celebration - it's a movement," said John Ferris, VP of Marketing at BTL. "By launching a national sweepstakes and spotlighting the incredible work of our providers, we're expanding access and empowering people to feel strong in their own skin. Emsculpt Week 2025 is about transformation, connection, and celebrating what's possible."

Since its debut in 2018, Emsculpt has led the category as the first and only non-invasive technology to use HIFEM^® to build muscle and sculpt the body. In 2020, the introduction of synchronized radiofrequency with Emsculpt NEO pushed results even further — delivering an average of 30% fat reduction and 25% more muscle in treated areas, with over 4 million treatments performed globally.

In 2024, BTL took the Emsculpt brand even further and introduced the next wellness revolution: The Functional Wellness. These new treatment protocols mark a major advancement in how the technology not only sculpts the body but also supports the patients with their day-to-day life — going beyond aesthetics to address mobility, flexibility, strength, muscle atrophy, range of motion, and expedited rehabilitation. A smarter, more complete approach to helping patients not just look better, but move and feel better too.

Whether you're a provider ready to share your success or a patient ready to experience what's next, National Emsculpt Week 2025 is your moment.

Learn more at www.bodybybtl.com.

About BTL:
Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 200+ patents and over 500 in-house engineers, BTL leverages technology and science to advance medical treatments. Its product portfolio includes , EMSCULPT NEO^®, EMFACE^®, EXION™, EXOMIND™, EMSELLA^®, and others.

Media Contact: samantha@samanthaslaven.com

BTL, a global leader in medical and aesthetic innovation, announces the launch of EMFACE® Eye, the first non-invasive procedure designed to reverse under-eye aging by restoring muscle tone and soft tissue support at its foundation.

This launch comes as EMFACE surpasses one million treatments globally, making it the fastest-growing facial aesthetic technology to date. It follows a record-breaking Q1 2025, with 70% sales growth in North America, underscoring the momentum behind the brand and its cutting-edge portfolio.

"The response to EMFACE has been phenomenal," said David Chmel, CEO of BTL Industries. "Reaching the one million treatment mark and reporting our strongest Q1 in history is a testament to the power of BTL innovation - and the trust our providers place in us. With EMFACE Eye, we're once again pushing the boundaries of what's possible in non-invasive aesthetics."

EMFACE Eye addresses one of the most delicate, and previously hard-to-treat, areas: under-eye region. While traditional approaches have often relied on injectables or surgery to reduce puffiness, dark circles, and hollowness, EMFACE Eye offers a breakthrough complement. It tones the lower orbicularis oculi muscle, lifts soft tissue, and enhances periorbital support.

In a quick 20-minute, needle-free procedure, patients experience an average reduction of 1.4mL in eye bag volume, a 28% reduction in crow's feet, and a 64% decrease in dark circles. These clinically backed results require no downtime, making it a breakthrough for both providers and patients alike.

Dr. Melanie Palm, M.D., MBA, a respected cosmetic dermatologist in Solana Beach, CA, praised the advancement:

"As a cosmetic dermatologist with a sizeable injectable practice, this is exactly what I've been waiting for. The results include noticeable brightening of the under-eye and buttressing of the infraorbital fat pad, significantly reducing fat pseudo-herniation."

"Emface restores structure and function to the facial anatomy in the most natural way, so we can count on superior results that drive high patient satisfaction."

With the addition of Eye applicators, the EMFACE platform now enables full-face balancing across all anatomical thirds—from forehead lifting to jawline sculpting to under-eye enhancement. The platform supports a comprehensive, layered approach that pairs seamlessly with injectable treatments to deliver natural, harmonious result. 

About BTL

Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 200+ patents and over 500 in-house engineers, BTL leverages technology and science to advance medical treatments. Its product portfolio includes , EMSCULPT NEO®, EMFACE®, EXION™, EXOMIND™, EMSELLA®, and others.

For more information, visit www.bodybybtl.com.

Media Contact – samantha@samanthaslaven.com

BTL, a global leader in aesthetic, wellness and longevity technologies, is thrilled to announce a new partnership with Nava Health, a premier provider of integrative holistic health and wellness solutions. This collaboration brings BTL's cutting-edge devices—Emsculpt Neo, Emsella, Emface, and Exion—to Nava Health's national network of health and wellness centers.

The partnership reflects a shared commitment to enhancing lives through advanced, results-driven technologies and personalized care. BTL's innovative offerings perfectly complement Nava Health's medical weight loss programs, hormone replacement therapy, functional nutrition, and regeneration services. Together, the two companies provide a seamless integration of wellness, aesthetics, and longevity.

"Nava Health is dedicated to providing holistic solutions that help people look and feel their best," said Alexis Gaus, Director of Aesthetics. "Integrating BTL's groundbreaking devices allows us to expand our offerings and provide our clients with effective, non-invasive treatments for body sculpting, facial rejuvenation, pelvic health, and overall wellness. This partnership is a natural fit for our mission."

BTL's devices are renowned for their advanced technology and proven results:

• Emsculpt Neo: Combines HIFEM+ and radiofrequency to reduce fat and build muscle in a single treatment, making it a perfect complement to Nava's medical weight loss solutions.
• Emsella: Revolutionizes pelvic floor health with non-invasive electromagnetic stimulation.
• Emface: Offers a needle-free solution for facial rejuvenation by improving muscle tone and skin quality.
• Exion: Delivers powerful results for improved skin tone and texture with unmatched versatility.

"We're excited to partner with Nava Health, a leader in holistic health and wellness," said Nathan Lanham, Director of National Accounts at BTL. "This collaboration underscores our shared dedication to innovation and delivering life-changing results for clients. Nava Health's expertise and reach will help bring the benefits of Emsculpt Neo, Emsella, Emface, and Exion to even more people across the country. Together, we are redefining wellness, aesthetics, and longevity."

With this partnership, Nava Health clients will now have access to cutting-edge technologies that align with their health and wellness goals, ensuring a transformative experience that goes beyond aesthetics.

For more information about BTL and Nava Health, please visit www.bodybybtl.com and www.navacenter.com.

About BTL
Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 200+ patents and over 500 in-house engineers, BTL leverages technology and science to advance medical treatments. Its product portfolio includes EMSCULPT NEO^®, EMFACE^®, EXION^®, EMSELLA^®, and others. For more information, visit www.bodybybtl.com

About Nava Health
Nava Health is a leading provider of integrative holistic health and wellness solutions, specializing in medical weight loss, functional medicine, hormone therapy, and regenerative treatments. With a mission to help people feel their best at every stage of life, Nava Health delivers personalized care through an integrative approach.

BTL, the innovator in medical and aesthetic technologies, is thrilled to introduce the EXOMIND, powered by ExoTMS technology - a state-of-the-art, non-invasive brain stimulation treatment designed to improve mental and emotional well-being.

EXOMIND is FDA-cleared for depression in the United States, and also approved by Health Canada and CE-marked for treating depression, anxiety symptoms, obsessive-compulsive disorder and excessive eating disorders.

"EXOMIND technology demonstrates our commitment to wellness by delivering natural, innovative solutions that empower individuals to reach their full potential," emphasized Filip Donner, Company's director. He continued, "This patient-friendly therapy aligns with our vision of promoting holistic health. Unlike conventional treatments, it provides a natural approach to mental wellness, fostering brain resilience without the side effects often associated with pharmaceuticals."

"Our record-breaking Q4, with over $220 million in global sales, is a testament to the growing demand for BTL's cutting-edge solutions," Donner added. "This achievement affirms the trust and confidence customers place in our technologies."

EXOMIND offers a pioneering treatment that appeals to patients seeking seamless, drug-free alternatives. In clinical studies, patients appreciate EXOMIND's  comfortable, walk-in, walk-out sessions lasting under 30 minutes. The device's ease of use allows for quick integration into medical practices, including family medicine and internal medicine practices.

"For my practice, EXOMIND has been a game-changer," said Dr. JD McCoy. "The device is easy to operate and gives our patients a unique offering they truly value." 

"The majority of my patients are on some form of antidepressant medication. With EXOMIND, we now offer an alternative that enhances patient well-being and provides them with the freedom to manage their mental wellness without relying solely on medication," added Dr. Yael Halaas.

About BTL
Founded in 1993, BTL is a global leader in medical devices, providing innovative solutions in dermatology, plastic surgery, med spas, orthopedics, joint and spine care, rehabilitation, dentistry, primary care, OB/GYN, and more. With 200+ patents and over 500 in-house engineers, BTL leverages technology and science to advance medical treatments. Its product portfolio includes EXOMIND™, EMSCULPT NEO®, EMFACE®, EXION™, EMSELLA®, and others. For more information, visit www.bodybybtl.com.